Is it appropriate to give a 250 mg/5 mL cefuroxime suspension to a 1‑year‑old child who cannot take amoxicillin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can You Give a 250mg/5mL Cefuroxime Suspension?

Yes, you can give a 250 mg/5 mL cefuroxime suspension to a 1-year-old child who cannot take amoxicillin, as cefuroxime is an acceptable alternative for community-acquired pneumonia in children with amoxicillin allergy.

Clinical Context and Rationale

For a 1-year-old child with presumed bacterial community-acquired pneumonia who cannot tolerate amoxicillin, the 2011 PIDS/IDSA guidelines explicitly list cefuroxime as an appropriate alternative oral cephalosporin 1. The guidelines specifically state that for children with a history of possible, nonserious allergic reactions to amoxicillin, "a trial of an oral cephalosporin that has substantial activity against S. pneumoniae, such as cefpodoxime, cefprozil, or cefuroxime, provided under medical supervision" is an acceptable option 1.

Dosing Specifications

For a 1-Year-Old Child:

  • Standard dose: 20-50 mg/kg/day divided every 12 hours 2
  • For the 250mg/5mL suspension:
    • Children aged 1-24 months: 125 mg twice daily (2.5 mL of the 250mg/5mL suspension) 3
    • Children aged 2-12 years: 250 mg twice daily (5 mL of the 250mg/5mL suspension) 3

For a typical 1-year-old (approximately 10 kg), give 125 mg (2.5 mL) twice daily after food.

Important Clinical Considerations

Advantages of Cefuroxime in This Setting:

  • Beta-lactamase stability: Effective against beta-lactamase-producing H. influenzae and M. catarrhalis 4
  • Adequate tissue penetration: Achieves concentrations exceeding MIC90 for common respiratory pathogens 4
  • Proven efficacy: Multiple studies demonstrate comparable efficacy to amoxicillin for respiratory infections 5, 6
  • Convenient dosing: Twice-daily administration (versus three times daily for amoxicillin) 5

Critical Caveats:

  1. Cross-reactivity risk: If the child has a history of serious hypersensitivity to amoxicillin (anaphylaxis, Stevens-Johnson syndrome), cefuroxime is contraindicated due to cross-reactivity between penicillins and cephalosporins 1. In such cases, use macrolides, levofloxacin, linezolid, or clindamycin instead.

  2. Administer with food: Cefuroxime axetil absorption is enhanced when given with food or milk 7. The suspension should be given after meals.

  3. Penicillin resistance considerations: For areas with significant penicillin-resistant S. pneumoniae, cefuroxime remains effective against intermediately resistant strains 8, though it may be less reliable than high-dose amoxicillin for highly resistant strains.

  4. Duration: Treat for minimum 5-10 days, with at least 48-72 hours beyond symptom resolution 1

Practical Administration

  • Shake well before each use
  • Mix the suspension according to manufacturer instructions
  • Can be mixed with milk, formula, or juice if needed 9
  • Refrigeration preferred but not required after reconstitution
  • Discard unused suspension after 14 days 9

When NOT to Use This Preparation

  • History of anaphylaxis or severe cutaneous reactions to beta-lactams
  • Suspected CA-MRSA (requires vancomycin or clindamycin) 1
  • Confirmed highly penicillin-resistant pneumococcus (MIC ≥4 µg/mL) - consider levofloxacin or linezolid instead 1

The 250mg/5mL preparation is appropriate and guideline-supported for this clinical scenario, with the dose adjusted based on the child's weight and age.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.